Welcome to LookChem.com Sign In|Join Free
  • or
2(3H)-Benzothiazolone, 3-[(2R)-2-methyl-3-[[(4-methylphenyl)sulfonyl]oxy]propyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

509148-20-3

Post Buying Request

509148-20-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

509148-20-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 509148-20-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,9,1,4 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 509148-20:
(8*5)+(7*0)+(6*9)+(5*1)+(4*4)+(3*8)+(2*2)+(1*0)=143
143 % 10 = 3
So 509148-20-3 is a valid CAS Registry Number.

509148-20-3Downstream Products

509148-20-3Relevant academic research and scientific papers

Benzimidazolidinone derivatives as muscarinic agents

-

, (2008/06/13)

Benzimidazolidinone derivative compounds, which increase acetylcholine signaling or effect in the brain, and highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes, pharmaceutical compositions comprising the same, as well as methods of treating psychosis using these compounds are disclosed.

Benzimidazolidinone derivatives as muscarinic agents

-

Page/Page column 24, (2010/02/06)

Benzimidazolidinone derivative compounds, which increase acetylcholine signaling or effect in the brain, and highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes, pharmaceutical compositions comprising the same, as well as methods of treating psychosis using these compounds are disclosed.

Benzimidazolidinone derivatives as muscarinic agents

-

, (2008/06/13)

Benzimidazolidinone derivative compounds, which increase acetylcholine signaling or effect in the brain, and highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes, pharmaceutical compositions comprising the same, as well as methods of treating psychosis using these compounds are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 509148-20-3